Speakers
Description
This session will bring together leading researchers to discuss quantitative methods for studying immune-related therapies and tumor-specific mechanisms in cancer to support the development of more effective treatments. Our objective is to highlight immune-focused treatments and models and their significance to cancer research, from immune-mediated treatment optimization, mechanisms underlying differential responses to immunotherapy, tumour-specific mechanisms, and antibody transfer processes.
This minisymposium will explore how immune mechanisms can improve the efficacy of radiation therapy for brain metastases; the complex role of PD-L1 in both activating and suppressing immune responses; insights into improving therapies for acute myeloid leukemia (AML) by establishing predictive models of preleukemia; and the movement of therapeutic antibodies throughout the body. Through the integration of diverse perspectives and approaches, this session will advance immune-focused cancer research and the use of mechanistic modelling to shepherd the development of more effective treatment strategies.
